DAIICHI SANKYO GROUP
DAIICHI SANKYO GROUP, a prominent player in the global pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the group has since achieved significant milestones, including advancements in oncology and cardiovascular treatments. Specialising in innovative medicines, DAIICHI SANKYO is renowned for its unique drug development capabilities, particularly in targeted therapies and biologics. The company’s commitment to research and development has positioned it as a leader in the pharmaceutical market, with notable achievements such as the successful launch of several blockbuster drugs. With a strong focus on improving patient outcomes, DAIICHI SANKYO continues to make strides in the healthcare sector, solidifying its reputation as a trusted name in pharmaceuticals.
DitchCarbon Score
How does DAIICHI SANKYO GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DAIICHI SANKYO GROUP's score of 55 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
DAIICHI SANKYO GROUP's reported carbon emissions
In 2023, Daiichi Sankyo Group reported total carbon emissions of approximately 4,430,241,000 kg CO2e, with significant contributions from Scope 3 emissions at about 4,430,241,000 kg CO2e, while Scope 1 and Scope 2 emissions were approximately 250,060 kg CO2e and 3,360 kg CO2e, respectively. This marks a notable increase in Scope 3 emissions compared to 2022, where they were about 1,809,230,000 kg CO2e. Daiichi Sankyo has set ambitious climate commitments, aiming to achieve net-zero greenhouse gas emissions by FY2050. The company has established a near-term target to reduce absolute Scope 1 and 2 emissions by 63% by FY2030 from a FY2015 baseline. Additionally, they plan to increase their sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, they aim for 70.6% of their suppliers, based on emissions, to have science-based targets by FY2025. In the near term, Daiichi Sankyo is also investing in renewable energy and CO2 emission neutralisation initiatives, including partnerships for planting seedlings to offset annual emissions. These efforts reflect their commitment to sustainability and reducing their overall carbon footprint across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 86,785,000 | 00,000,000 | 000,000 | 000,000 |
| Scope 2 | 96,080,000 | 000,000,000 | 0,000 | 0,000 |
| Scope 3 | 609,954,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DAIICHI SANKYO GROUP is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
